synuclein alpha
| GO Term | Evidence Code | PMID |
|---|---|---|
| negative regulation of transcription by RNA polymerase II | ||
| microglial cell activation | ||
| positive regulation of receptor recycling | ||
| positive regulation of neurotransmitter secretion | ||
| negative regulation of protein kinase activity |
| GO Term | Evidence Code | PMID |
|---|---|---|
| SNARE binding | ||
| magnesium ion binding | ||
| transcription cis-regulatory region binding | ||
| actin binding | ||
| enzyme inhibitor activity |
| Gene Ontology |
|---|
| chemical synaptic transmission |
| cuprous ion binding |
| metal ion binding |
| regulation of dopamine secretion |
| synapse organization |
| InterPro |
|---|
| Alpha-synuclein |
| Synuclein |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060367 | Parkinson's disease 1 | |
| DOID:0060895 | Parkinson's disease 4 | |
| DOID:10652 | Alzheimer's disease | |
| DOID:12217 | Lewy body dementia | |
| DOID:14330 | Parkinson's disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026